|
blowfish posted:no, the market is full of rational actors, who use accurate and complete information to inform their investment strategy, you see~ VCs are often gambling with other people's money so there isn't much downside to losing.
|
#
¿
Feb 8, 2016 23:02
|
|
|
|
| # ¿ May 2, 2024 01:21 |
|
|
Arsenic Lupin posted:And holy cow, Theranos, what were you smoking? There are many companies working in this space and theranos isn't the only one making big claims. Pathway genomics got called out by CBS last night for exagerating too. It's a large market, that won't go anywhere as along as people exist. The liquid biopsy cancer market alone is estimated to have a cap around 20 billion dollars. 100s of millions (maybe billions at this point?) are being thrown at companies to commercialize lab tests. It's not too surprising that some are trying to get a first mover advantage, even if that means exaggerating their efficacy. But yeah it was very obvious to other people in the field that Theranos was full of poo poo. There are some physical constraints on these problems that require a full blood draw and you can't just magic them away. There are some paths forward but are likely many years, maybe decades, away from being clinically viable.
|
|
#
¿
Feb 10, 2016 19:46
|
|
|
Bastard Tetris posted:As an (ex)-insider: I don't know how much they were exaggerating, but the C-level folks were the cart driving the horse when it came to a lot of things, they wanted to be first to market and wanted to sell a lab-developed test as an advisory tool while working with physicians, which is all good and legal. As far as I could tell from where I sat this was a letter they got from FDA in November, it got addressed, and a few pre-clinical tests are underway. Full disclosure, I work for a competitor. They were exaggerating quite a bit. Current sequencing technology is too noisy to detect circulating tumor DNA reliably. There just isn't enough ctDNA in the blood at early stages. Either the cancer is further along (at least stage 2) or the test will require more blood & sequencer time. Both of the latter drive up the cost of the test. Based on the prices on their website, they probably are either taking a HUGE loss or don't have a reliable test.
|
|
#
¿
Feb 11, 2016 21:19
|
|
|
Bastard Tetris posted:Neither would surprise me. I'm so glad I'm out of that mess. I wouldn't want to be working for someone making misleading claims that's for sure, but it's a great sector to be in. It's technology that will have big impacts on peoples lives even with it's current limitations. There will be some big winners regardless of a tech bust.
|
|
#
¿
Feb 11, 2016 22:55
|
|
|
Dirk the Average posted:What the gently caress do you need wifi for on a juicer? To make it tamper resistant so you aren't able to use 3rd party juice packets.
|
|
#
¿
Apr 1, 2016 02:23
|
|